Photodynamische Therapie mit Methylaminooxopentanoat (MetvixR) und einer Breitbandlichtquelle (PhotoDyn 501): Praktische Erfahrungen bei Problem-Patienten mit Aktinischen Keratosen und Basalzellkarzinomen. Photodynamic therapy with methylaminooxopentanoate (MetvixR) and a broad band light source (PhotoDyn 501): Experiences in complicated patients with actinic keratoses and basal cell carcinomas
- 1 December 2004
- journal article
- research article
- Published by Wiley in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
- Vol. 2 (12) , 992-999
- https://doi.org/10.1046/j.1439-0353.2004.04793.x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Topical photodynamic therapy in the treatment of actinic keratoses and Bowen’s disease in transplant recipientsTransplantation, 2004
- A Trial of Short Incubation, Broad-Area Photodynamic Therapy for Facial Actinic Keratoses and Diffuse PhotodamageArchives of Dermatology, 2004
- Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: Results of a prospective randomized multicenter trialJournal of the American Academy of Dermatology, 2003
- Photodynamic TherapyAmerican Journal of Clinical Dermatology, 2003
- Photodynamic Therapy and Topical Aminolevulinic AcidAmerican Journal of Clinical Dermatology, 2003
- Methyl aminolevulinate (Metvix®) photodynamic therapy - practical pearlsJournal of Dermatological Treatment, 2003
- Clinical efficacy of methyl aminolevulinate (Metvix®) photodynamic therapyJournal of Dermatological Treatment, 2003
- The role of light in the treatment of non-melanoma skin cancer using methyl aminolevulinateJournal of Dermatological Treatment, 2003
- The nature of solar keratosis: A critical review in historical perspectiveJournal of the American Academy of Dermatology, 2000
- Photodynamic therapy in dermatologyJournal of the American Academy of Dermatology, 2000